Abstract
We examined the effects of antihypertensive drugs, exercise training, and combinations thereof on insulin sensitivity (IS), and the association between this relation and sympathetic activity, muscle fiber composition, and capillary density in spontaneously hypertensive rats (SHR). Six-week-old male SHR were allocated to 7 groups: a control group (C), and groups treated with azelnidipine (Aze) (a calcium channel blocker), olmesartan (Olm) (an angiotensin II type 1 receptor blocker), exercise training (Exe), and combinations of drugs and exercise training (Aze+Exe, Olm+Exe, and Olm+Aze+Exe). At age 18 weeks, IS and sympathetic activity were evaluated by an euglycemic hyperinsulinemic glucose clamp technique and power spectral analysis of systolic blood pressure, respectively. After the experiments, capillary density and muscle fiber composition in soleus muscle were examined. Aze or Exe alone significantly increased IS associated with a significant reduction in sympathetic activity. Olm alone tended to increase IS with little change in sympathetic activity. Aze, Olm, or Exe significantly increased the capillary density and percentage of insulin-sensitive type I fiber. A combination of Aze and Exe or a combination of Olm and Exe tended to increase IS compared with each drug therapy alone. There were significant correlations between IS and sympathetic activity, capillary density, and the percentage of type I fiber in all the rats. We found that Aze improved IS more substantially compared with Olm in SHR. We also found that Aze, Olm, Exe, and combinations thereof improved IS, probably through the modulation of sympathetic activity or capillarity and muscle fiber type in skeletal muscles.
Similar content being viewed by others
Article PDF
References
Natali A, Santoro D, Palombo C, et al: Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 1991; 17: 170–178.
Melancon S, Bachelard H, Badeau M, et al: Effects of high-sucrose feeding on insulin resistance and hemodynamic responses to insulin in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2006; 290: H2571–H2581.
Hedman A, Reneland R, Lithell HO : Alterations in skeletal muscle morphology in glucose-tolerant elderly hypertensive men: relationship to development of hypertension and heart rate. J Hypertens 2000; 18: 559–565.
Frisk-Holmberg M, Essen B, Fredrikson M, Strom G, Wibell L : Muscle fibre composition in relation to blood pressure response to isometric exercise in normotensive and hypertensive subjects. Acta Med Scand 1983; 213: 21–26.
Prewitt RL, Chen II, Dowell R : Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol 1982; 243: H243–H251.
Ben Bachir-Lamrini L, Sempore B, Mayet MH, Favier RJ : Evidence of a slow-to-fast fiber type transition in skeletal muscle from spontaneously hypertensive rats. Am J Physiol 1990; 258: R352–R357.
Arauz-Pacheco C, Lender D, Snell PG, et al: Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects. Am J Hypertens 1996; 9: 1172–1178.
Scherrer U, Sartori C : Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96: 4104–4113.
Lithell HO : Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 1991; 14: 203–209.
Yagi S, Goto S, Yamamoto T, Kurihara S, Katayama S : Effect of cilnidipine on insulin sensitivity in patients with essential hypertension. Hypertens Res 2003; 26: 383–387.
Tomiyama H, Yambe M, Yamada J, et al: Discrepancy between improvement of insulin sensitivity and that of arterial endothelial function in patients receiving antihypertensive medication. J Hypertens 2007; 25: 883–889.
Kihara A : Effect of the calcium antagonist nicardipine hydrochloride on glucose tolerance and insulin secretion. Am Heart J 1991; 122: 363–369.
Lind L, Berne C, Pollare T, Lithell H : Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study. J Hum Hypertens 1995; 9: 137–141.
Moan A, Hoieggen A, Seljeflot I, et al: The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity. J Hypertens 1996; 14: 1093–1097.
Kohno K, Matsuoka H, Takenaka K, et al: Renal depressor mechanisms of physical training in patients with essential hypertension. Am J Hypertens 1997; 10: 859–868.
Minami N, Mori N, Nagasaka M, et al: Mechanism behind augmentation in baroreflex sensitivity after acute exercise in spontaneously hypertensive rats. Hypertens Res 2006; 29: 117–122.
Brown DR, Brown LV, Patwardhan A, Randall DC : Sympathetic activity and blood pressure are tightly coupled at 0.4 Hz in conscious rats. Am J Physiol 1994; 267: R1378–R1384.
Takada M, Ura N, Higashiura K, et al: Effects of cilnidipine on muscle fiber composition, capillary density and muscle blood flow in fructose-fed rats. Hypertens Res 2001; 24: 565–572.
Kawamura T, Yoshida K, Sugawara A, et al: Regulation of skeletal muscle peroxisome proliferator–activated receptor gamma expression by exercise and angiotensin-converting enzyme inhibition in fructose-fed hypertensive rats. Hypertens Res 2004; 27: 61–70.
Grim M, Carlson BM : Alkaline phosphatase and dipeptidylpeptidase IV staining of tissue components of skeletal muscle: a comparative study. J Histochem Cytochem 1990; 38: 1907–1912.
Cabassi A, Vinci S, Cantoni AM, et al: Sympathetic activation in adipose tissue and skeletal muscle of hypertensive rats. Hypertension 2002; 39: 656–661.
Julius S, Gudbrandsson T, Jamerson K, Tariq Shahab S, Andersson O : The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991; 9: 983–986.
Deibert DC, DeFronzo RA : Epinephrine-induced insulin resistance in man. J Clin Invest 1980; 65: 717–721.
McCarty MF : Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytes. Med Hypotheses 2004; 62: 830–838.
Nowak L, Adamczak M, Wiecek A : Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 2005; 18: 1470–1475.
Trayhurn P, Duncan JS, Hoggard N, Rayner DV : Regulation of leptin production: a dominant role for the sympathetic nervous system? Proc Nutr Soc 1998; 57: 413–419.
Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL : Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401: 73–76.
Lindqvist M, Kahan T, Melcher A, Ekholm M, Hjemdahl P : Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity. J Hypertens 2007; 25: 169–175.
Shokoji T, Fujisawa Y, Kiyomoto H, et al: Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats. Hypertens Res 2005; 28: 1017–1023.
Kimura Y, Hirooka Y, Sagara Y, Sunagawa K : Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity. Clin Exp Hypertens 2007; 29: 13–21.
Nap A, Balt JC, Pfaffendorf M, Van Zwieten PA : Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta. J Hypertens 2002; 20: 1821–1828.
Kamide K, Rakugi H, Higaki J, et al: The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. Am J Hypertens 2002; 15: 66–71.
Laterza MC, de Matos LD, Trombetta IC, et al: Exercise training restores baroreflex sensitivity in never-treated hypertensive patients. Hypertension 2007; 49: 1298–1306.
Hudlicka O : Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation? Microcirculation 1998; 5: 5–23.
Igase M, Strawn WB, Gallagher PE, Geary RL, Ferrario CM : Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1–7) expression in the aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2005; 289: H1013–H1019.
Kitayama H, Maeshima Y, Takazawa Y, et al: Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries. Am J Hypertens 2006; 19: 718–727.
Scheidegger KJ, Nelissen-Vrancken MH, Leenders PJ, et al: Structural adaptation to ischemia in skeletal muscle: effects of blockers of the renin-angiotensin system. J Hypertens 1997; 15: 1455–1462.
Melo RM, Martinho E Jr, Michelini LC : Training-induced, pressure-lowering effect in SHR: wide effects on circulatory profile of exercised and nonexercised muscles. Hypertension 2003; 42: 851–857.
James DE, Jenkins AB, Kraegen EW : Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am J Physiol 1985; 248: E567–E574.
Higashiura K, Ura N, Takada T, et al: The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats. Am J Hypertens 2000; 13: 290–297.
Lin J, Wu H, Tarr PT, et al: Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002; 418: 797–801.
Benson SC, Pershadsingh HA, Ho CI, et al: Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 2004; 43: 993–1002.
Oizumi K, Nishino H, Miyake S, et al: Hemodynamic changes following long-term administration of CS-905, a novel dihydropyridine calcium blocker, in conscious SHR. Jpn J Pharmacol 1990; 54: 1–6.
Nakamoto M, Ohya Y, Sakima A, Yamazato M, Takishita S : Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats. Hypertens Res 2007; 30: 359–366.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guo, Q., Minami, N., Mori, N. et al. Effects of Antihypertensive Drugs and Exercise Training on Insulin Sensitivity in Spontaneously Hypertensive Rats. Hypertens Res 31, 525–533 (2008). https://doi.org/10.1291/hypres.31.525
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.525